Activation of the inflammatory response system has been related to the pathophysiology of schizophrenia by several recent studies. Schizophrenic patients have varied levels of proinflammatory cytokines, such as interleukin (IL)-1,-6, and tumor necrosis factor (TNF)␣ in their peripheral blood or cerebrospinal fluid.
Several studies measuring the levels of proinflammatory cytokines, such as interleukin (IL)-1, -6, and TNF-␣ in the peripheral blood or cerebrospinal fluid of schizophrenic patients have indicated dysregulation of these cytokines in schizophrenia. [1] [2] [3] [4] [5] [6] We recently demonstrated that plasma IL-1␤ levels were increased in a group of acute first admission drug-free schizophrenic patients as compared to healthy controls. 3 Others have linked elevated IL-6 and TNF-␣ levels to the course, the treatment or progression of schizophrenic illness. [4] [5] [6] Although these cytokine abnormalities, as well as the other immunological deviations associated with psychiatric disorders, have been known for some time, the causal relationship has remained enigmatic. Theoretically, the increase in the levels of the pro-inflammatory cytokines can simply be a consequence of mental stress or sleep deprivation associated with the onset or exacerbation of the disease, 11, 12 without having a role in the pathogenesis of the disease. On the other hand, these cytokines can modify the metabolism of neurotransmitters or influence neural development. 7, 8 IL-1 has been described as an astroglial growth factor and it has been suggested to have a role in the development process of the brain and to be implicated in acute and chronic neurodegeneration. 8, 13 Cytokines are now known to have multiple modulatory effects on cellular growth and differentiation. These cytokines could therefore be of primary pathogenic importance, either in the acute disease phase or during those stages of brain development which possibly influence the sensitivity of a person to schizophrenia in later life. A geneviral model of schizophrenia suggests that exposure to viruses initiates an immunological process that somehow disorganizes development of the fetal brain. 14, 15 All three genes of the IL-1 gene complex (IL-1␣, IL-1␤, IL-1RA) are clustered on the long arm of human chromosome 2 in a region q13-q21. 16 The gene encoding IL-1RA has a variable number of tandem repeat polymorphisms in intron 2. 17 In the IL-1␤ gene there are at least two bi-allelic base exchange polymorphisms, one at the promoter region at position −511, 18 and the other at position +3953 in the 5th exon. 19 There is now evidence that genes of Il-1␣, IL-1␤, and IL-1RA, are polymorphic and the various alleles may have a differential regulatory effect on cytokine production and, consequently, the allele frequencies are often aberrant in various diseases of an autoimmune or inflammatory nature. 20, 21 We analyzed the polymorphism of the IL-1 gene complex in 50 schizophrenic patients and in 400 healthy blood donors. Our results on the IL-1 gene complex, suggest a genetic involvement in the observed dysregulation of these cytokines in schizophrenia, and thus, contrast a previous report which did not find any evidence for the association or linkage between IL-2 receptor ␤ chain, Il-1␤, and schizophrenia. 22 The data shown in Table 1 demonstrate that distribution of the various genotypes was quite the same in schizophrenia patients as in the controls (Hardy-Weinberg equilibrium). However, the frequencies of the IL-1␣ (−889) allele 2, IL1␤ (−511) allele 1 and IL-1RA allele 1 tended to be somewhat higher in the schizophrenia group. These alleles are known to locate in the same IL-1 complex haplotype. 10 The number of carriers of this haplotype as well as the haplotype frequency were clearly higher in the patient group (P = 0.026 and P = 0.0266, respectively). The biological effect seems to require homozygotism as the number of IL-1␣ (−899) allele 2, IL-1␤ (−511) allele 1 and IL-1RA allele 1 homozygotes was significantly higher in schizophrenic patients when compared to controls (P = 0.0006) ( Table 2 ).
In conclusion, our findings on the allelism of the IL-1 gene complex suggest that the cytokine aberrations in schizophrenia are, at least partly, genetically determined. It could be speculated that the genetics of infection is somewhat different in schizophrenic patients. This could have etiopathogenic importance bearing in mind the theories of maternal viral infection leaving the foetus at greater risk of developing immunologically mediated brain changes possibly leading to schizophrenia. 15 Future studies on the genetics of immunological changes in schizophrenia should include the mothers of the patients as well.
Methods

Subjects
The patient sample consisted of 50 patients (age range 19-61 years) meeting the DSM-IV criteria for schizophrenia. Twenty patients met the criteria for paranoid, nineteen for disorganized, eleven for the undifferentiated form of acute or chronic schizophrenia. Diagnoses were assigned by a Structured Clinical Interview for DSM-IV Axis I Disorders-clinician version (SCID-I/CV). 23 Patients were recruited from the Departments of Psychiatry at Helsinki University Central Hospital and at Central Hospital of South Carelia. They all gave their written informed consent for the study after its nature had been fully explained. The study was approved by the ethics committees of both hospitals.
The control group consisted of 400 healthy blood donors (age range 18-60 years, from the Finnish Red Cross Blood Transfusion Service, Tampere). Controls, as well patients, in this study were somatically healthy Caucasian Finnish citizens.
DNA isolation and polymorphism screening
From all subjects 10 ml of venous blood was drawn into EDTA vacuum tubes and immediately frozen at −20°C for later DNA isolation. Genomic DNA was isolated from the blood samples by using the salting-out method. 24 Il-1Ra: A variable number of tandem repeats was analyzed as described earlier. 17 Briefly, oligonucleotides 5′CTC AGC AAC ACT CCT AT3′ and 5′TCC TGG TCT GCA GGT AA3′ were used as primers in polymerase chain reaction (PCR). Conditions used were: 96°C for 1 min followed by 35 cycles of 94°C for 1 min, 60°C for 1 min, 70°C for 1 min, and finally 72°C for 5 min. The PCR products were analyzed by electrophoresis on a 2% agarose gel stained with ethidium bromide.
IL-1␤ (−511): The region that contains the AvaI polymorphic site at the position −511 of the IL-1␤ gene 18 was amplified by PCR. The oligonucleotides 5′TGG CAT TGA TCT GGT TCA TC3′ and 5′GTT TAG GAA TCT TCC CAC TT3′ flanking this region were used as primers. PCR conditions were as follows: 95°C for 2 min, 55°C for 1 min, 74°C for 1 min, then 38 cycles of 95°C for 1 min, 55°C for 1 min, 74°C for 1 min, and finally 74°C for 4 min. The products were digested with 6 units of AvaI at 37°C for 3 h. Fragments were analyzed by electrophoresis on 9% polyacrylamide gel electrophoresis (PAGE), stained with ethidium bromide. This gave products of 190 bp + 114 bp (allele 1) and 304 bp (allele 2).
IL-1␣ (−889): The polymorphic region of the IL-1␣ was amplified as previously described 25 using oligonucleotide primers 5′ AAG CTT GTT CTA CCA CCT GAA CTA GGC3′ and 5′TTA CAT ATG AGC CTT CCA TG3′ based on the DNA sequences that flank the polymorphic site. Conditions used were a denaturing step of 96°C for 1 min and then 40 cycles of 94°C for 1 min, 51°C for 1 min, 72°C for 1 min, and finally 72°C for 4 min and 55°C for 5 min. The products were digested with NcoI and the resultant products were analyzed on 9% PAGE. This gave products of 83 bp + 16 bp (allele 1) and 99 bp (allele 2).
Statistical analysis
The significance of the differences of the allele frequencies in the control and patient groups was compared using the 2 × 2 tables and a standard 2 -test using Bonferroni correction. Statistical calculations were performed by using the Statistica software (StatSoft Inc, Tulsa, OK, USA).
